Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 105

Sort by

Sort Order Select

Journal Articles

Prophylactic Corticosteroids Allow Safe Outpatient Administration of Axicabtagene Ciloleucel with Comparable Toxicities to Other CAR-T Therapies in Large Cell Lymphoma

Steven Baker, Asad Bashey, Lizamarie Bachier-Rodriguez, Lawrence E Morris, H Kent Holland, Justin Laporte, Scott R. Solomon, Melissa Sanacore, Melhem Solh

Blood (2024) 144 (Supplement 1): 2363.

https://doi.org/10.1182/blood-2024-210395

Published: 2024

Journal Articles

Improved Outcomes of Adult Patients with Philadelphia-like Acute Lymphoblastic Leukemia (Ph-Like ALL) Treated within an Integrated Leukemia/Transplant Program with Incorporation of Pediatric Inspired Regimens and Early Allogeneic Transplant

Asad Bashey, Xu Zhang, H. Kent Holland, Lawrence E Morris, Lizamarie Bachier-Rodriguez, Scott R. Solomon, Melhem M. Solh

Blood (2024) 144 (Supplement 1): 1450.

https://doi.org/10.1182/blood-2024-209117

Published: 2024

Journal Articles

Comparison of FLAG-Idarubicin to FLAG-Idarubicin Plus Venetoclax for Treatment of Newly Diagnosed AML in Patients Eligible for Intensive Induction. Analysis of 200 Consecutive Patients Treated at a Single Center

Asad Bashey, Xu Zhang, Lawrence E Morris, H. Kent Holland, Lizamarie Bachier-Rodriguez, Scott R. Solomon, Melhem M. Solh

Blood (2024) 144 (Supplement 1): 1522.

https://doi.org/10.1182/blood-2024-209199

Published: 2024

Journal Articles

The Degree of HLA-DPB1 Mismatch Predicted By Evolutionary Divergence Scoring Informs the Risk of Chronic Graft-Versus-Host Disease after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Melhem M. Solh, Asad Bashey, Michael T Aubrey, Brian Freed, Christina Roark, Lawrence E Morris, H Kent Holland, Lizamarie Bachier-Rodriguez, Xu Zhang, Scott R. Solomon

Blood (2024) 144 (Supplement 1): 4913.

https://doi.org/10.1182/blood-2024-210329

Published: 2024

Journal Articles

Extracorporeal Photopheresis (ECP) in the Era of New Chronic Graft-Versus-Disease (GVHD) Therapies

Melhem M. Solh, Asad Bashey, Lawrence E Morris, Lizamarie Bachier-Rodriguez, H. Kent Holland, Xu Zhang, Rajveer Singh, Katelin Jackson, Scott R. Solomon

Blood (2024) 144 (Supplement 1): 4912.

https://doi.org/10.1182/blood-2024-208659

Published: 2024

Journal Articles

High HLA Evolutionary Divergence in Donor HLA-B Locus Impacts Transplant Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide

Melhem M. Solh, Scott R. Solomon, Christina Roark, Michael T Aubrey, Lawrence E Morris, H Kent Holland, Lizamarie Bachier-Rodriguez, Brian Freed, Asad Bashey

Blood (2024) 144 (Supplement 1): 4948.

https://doi.org/10.1182/blood-2024-210627

Published: 2024

Journal Articles

Intensive Conditioning with Fludarabine Plus Melphalan Versus Total Body Irradiation Prior to Haploidentical Transplant and Post-Transplant Cyclophosphamide

Scott R. Solomon, Melissa Sanacore, Asad Bashey, Katelin C Jackson, Lizamarie Bachier Rodriguez, Lawrence E Morris, H. Kent Holland, Melhem M. Solh

Blood (2024) 144 (Supplement 1): 3501.

https://doi.org/10.1182/blood-2024-200103

Published: 2024

Journal Articles

Survival Impact of Early Versus Late Discontinuation of Immunosuppression after Allogeneic Stem Cell Transplantation

Justin Laporte, Katelin Jackson, Xu Zhang, Asad Bashey, Lawrence E Morris, Lizamarie Bachier Rodriguez, Melhem M. Solh, Scott R. Solomon, H. Kent Holland

Blood (2024) 144 (Supplement 1): 7333.

https://doi.org/10.1182/blood-2024-200207

Published: 2024

Journal Articles

Safety and Efficacy of Ibrutinib Added to Rituximab-Based Primary Therapy of Chronic Graft-Versus-Host-Disease

Scott R. Solomon, Melissa Sanacore, Lizamarie Bachier Rodriguez, Latasha McCoy, Caitlin Guzowski, Katelin C Jackson, Xu Zhang, H. Kent Holland, Lawrence E Morris, Melhem M. Solh, Asad Bashey

Blood (2024) 144 (Supplement 1): 3528.

https://doi.org/10.1182/blood-2024-199618

Published: 2024

Journal Articles

Compared to Venetoclax Plus Hypomethylating Agents, High Dose Cytarabine Based Intensive Chemotherapy Induction for Newly Diagnosed Acute Myeloid Leukemia (AML) Leads to a Faster Remission Resulting in Better Survival

Melhem M. Solh, Scott R. Solomon, Lawrence Morris, H Kent Holland, Lizamarie Bachier-Rodriguez, Xu Zhang, Katelin C Jackson, Asad Bashey

Blood (2023) 142 (Supplement 1): 2896.

https://doi.org/10.1182/blood-2023-186117

Published: 2023

Journal Articles

Intrathecal Chemotherapy As Treatment for Chimeric Antigen Receptor T Cell (CAR T) Therapy Associated Neurotoxicity

Melhem M. Solh, Asad Bashey, Lawrence Morris, Lizamarie Bachier-Rodriguez, H Kent Holland, Xu Zhang, Katelin C Jackson, Scott R. Solomon

Blood (2023) 142 (Supplement 1): 2138.

https://doi.org/10.1182/blood-2023-186585

Published: 2023

Journal Articles

Impact of HLA-DQ Heterodimer Group (G1/G2) Mismatch on Relapse and Survival Following Haploidentical Donor Transplantation

Scott R. Solomon, Michael T Aubrey, Xu Zhang, Lizamarie Bachier-Rodriguez, Lawrence Morris, H. Kent Holland, Christina Roark, Katelin C Jackson, Asad Bashey, Melhem M. Solh

Blood (2023) 142 (Supplement 1): 4984.

https://doi.org/10.1182/blood-2023-182503

Published: 2023

Journal Articles

Immunosuppression Free at One-Year Post Haploidentical Hematopoietic Cell Transplantation (Haplo) with Post-Transplant Cyclophosphamide (PTCY)

Melhem M. Solh, Scott R. Solomon, Lawrence Morris, Lizamarie Bachier-Rodriguez, H Kent Holland, Xu Zhang, Katelin C Jackson, Asad Bashey

Blood (2023) 142 (Supplement 1): 4945.

https://doi.org/10.1182/blood-2023-187505

Published: 2023

Journal Articles

Comparison of Condensed to Standard Schedule of High Dose Cytarabine Consolidation for Acute Myeloid Leukemia in First Complete Remission

Melhem M. Solh, Kristen Kilby, Jimena Baron, Xu Zhang, Asad Bashey, H Kent Holland, Lizamarie Bachier-Rodriguez, Lawrence Morris, Scott R. Solomon

Blood (2023) 142 (Supplement 1): 5939.

https://doi.org/10.1182/blood-2023-186662

Published: 2023

Journal Articles

Post-Transplant Maintenance in AML and MDS Patients Undergoing Non-Myeloablative Peripheral Blood Stem Cell Transplant with Post-Transplant Cyclophosphamide

Lan Lei, Asad Bashey, Scott R. Solomon, Lawrence Morris, H Kent Holland, Melhem M. Solh, Katelin C Jackson, Xu Zhang, Lizamarie Bachier Rodriguez

Blood (2023) 142 (Supplement 1): 6968.

https://doi.org/10.1182/blood-2023-190663

Published: 2023

Journal Articles

Effect of HLA-DPB1 Mismatch on Incidence and Severity of Chronic Graft-Versus-Host Disease Following Haploidentical Transplantation

Scott R. Solomon, Melhem M. Solh, Asad Bashey, Lizamarie Bachier-Rodriguez, Xu Zhang, Lawrence Morris, H. Kent Holland

Blood (2023) 142 (Supplement 1): 2193.

https://doi.org/10.1182/blood-2023-182495

Published: 2023

Journal Articles

Impact of an HLA-DPB1 Non-Permissive Mismatch By the Revised T Cell Epitope (TCE)-Core Algorithm on Survival Following Haploidentical Donor Transplantation (HIDT) with Post-Transplant Cyclophosphamide (PTCy)

Scott R. Solomon, Michael T Aubrey, Lizamarie Bachier-Rodriguez, Melhem M. Solh, Katelin C Jackson, Xu Zhang, Christina Roark, H. Kent Holland, Lawrence Morris, Asad Bashey

Blood (2023) 142 (Supplement 1): 2240.

https://doi.org/10.1182/blood-2023-182499

Published: 2023

Journal Articles

Effect of CMV Reactivation and Letermovir Use on Chronic Gvhd Incidence Following Haploidentical Donor Transplantation with Post-Transplant Cyclophosphamide

Scott R. Solomon, Lizamarie Bachier-Rodriguez, Xu Zhang, H. Kent Holland, Lawrence E. Morris, Jr., Asad Bashey, Melhem Solh

Blood (2022) 140 (Supplement 1): 7647–7648.

https://doi.org/10.1182/blood-2022-162788

Published: 2022

Journal Articles

A Phase I California Cancer Consortium Study of Blinatumomab/Lenalidomide in Relapsed/Refractory Non-Hodgkin Lymphoma: Updated Results and Immune Correlative Analyses

Blood (2022) 140 (Supplement 1): 9446–9447.

https://doi.org/10.1182/blood-2022-167173

Published: 2022

Journal Articles

Frequency and Clinical Significance of Mixed T-Cell Chimerism Following Myeloablative Busulfan and Cyclophosphamide Conditioning in HLA -Matched Donor Transplants for Myeloid Malignancies: An Analysis of 179 Patients Transplanted at a Single Center

Asad Bashey, Xu Zhang, Scott R. Solomon, Lizamarie Bachier-Rodriguez, H. Kent Holland, Lawrence E. Morris, Jr., Melhem Solh

Blood (2022) 140 (Supplement 1): 7568–7569.

https://doi.org/10.1182/blood-2022-156852

Published: 2022

NARROW

Prophylactic Corticosteroids Allow Safe Outpatient Administration of Axicabtagene Ciloleucel with Comparable Toxicities to Other CAR-T Therapies in Large Cell Lymphoma

Improved Outcomes of Adult Patients with Philadelphia-like Acute Lymphoblastic Leukemia (Ph-Like ALL) Treated within an Integrated Leukemia/Transplant Program with Incorporation of Pediatric Inspired Regimens and Early Allogeneic Transplant

Comparison of FLAG-Idarubicin to FLAG-Idarubicin Plus Venetoclax for Treatment of Newly Diagnosed AML in Patients Eligible for Intensive Induction. Analysis of 200 Consecutive Patients Treated at a Single Center

The Degree of HLA-DPB1 Mismatch Predicted By Evolutionary Divergence Scoring Informs the Risk of Chronic Graft-Versus-Host Disease after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Extracorporeal Photopheresis (ECP) in the Era of New Chronic Graft-Versus-Disease (GVHD) Therapies

High HLA Evolutionary Divergence in Donor HLA-B Locus Impacts Transplant Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide

Intensive Conditioning with Fludarabine Plus Melphalan Versus Total Body Irradiation Prior to Haploidentical Transplant and Post-Transplant Cyclophosphamide

Survival Impact of Early Versus Late Discontinuation of Immunosuppression after Allogeneic Stem Cell Transplantation

Safety and Efficacy of Ibrutinib Added to Rituximab-Based Primary Therapy of Chronic Graft-Versus-Host-Disease

Compared to Venetoclax Plus Hypomethylating Agents, High Dose Cytarabine Based Intensive Chemotherapy Induction for Newly Diagnosed Acute Myeloid Leukemia (AML) Leads to a Faster Remission Resulting in Better Survival

Intrathecal Chemotherapy As Treatment for Chimeric Antigen Receptor T Cell (CAR T) Therapy Associated Neurotoxicity

Impact of HLA-DQ Heterodimer Group (G1/G2) Mismatch on Relapse and Survival Following Haploidentical Donor Transplantation

Immunosuppression Free at One-Year Post Haploidentical Hematopoietic Cell Transplantation (Haplo) with Post-Transplant Cyclophosphamide (PTCY)

Comparison of Condensed to Standard Schedule of High Dose Cytarabine Consolidation for Acute Myeloid Leukemia in First Complete Remission

Post-Transplant Maintenance in AML and MDS Patients Undergoing Non-Myeloablative Peripheral Blood Stem Cell Transplant with Post-Transplant Cyclophosphamide

Effect of HLA-DPB1 Mismatch on Incidence and Severity of Chronic Graft-Versus-Host Disease Following Haploidentical Transplantation

Impact of an HLA-DPB1 Non-Permissive Mismatch By the Revised T Cell Epitope (TCE)-Core Algorithm on Survival Following Haploidentical Donor Transplantation (HIDT) with Post-Transplant Cyclophosphamide (PTCy)

Effect of CMV Reactivation and Letermovir Use on Chronic Gvhd Incidence Following Haploidentical Donor Transplantation with Post-Transplant Cyclophosphamide

A Phase I California Cancer Consortium Study of Blinatumomab/Lenalidomide in Relapsed/Refractory Non-Hodgkin Lymphoma: Updated Results and Immune Correlative Analyses

Frequency and Clinical Significance of Mixed T-Cell Chimerism Following Myeloablative Busulfan and Cyclophosphamide Conditioning in HLA -Matched Donor Transplants for Myeloid Malignancies: An Analysis of 179 Patients Transplanted at a Single Center

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only